AzTrials
AzTrials

Cerebral Palsy (CP)NCT06596525

Effects of Barefoot vs. Shod Whole Body Vibration Training in Children With Cerebral Palsy

A study testing Conventional physical therapy, Barefoot Whole Body Vibration Training (WBVTb) and Shod Whole Body Vibration Training (WBVTs) in people with Cerebral Palsy (CP), run by Trakya University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Cerebral palsy (CP) refers to a group of lifelong conditions that affect the development of movement and coordination that lead to activity limitations due to damage to the developing fetal or neonatal brain tissue. Although the brain lesion is static, it can lead to progressive musculoskeletal system problems. Read more about this study

Who is it for?
Ages 3 to 18 years
Conditions the study is for
Cerebral Palsy (CP)
What is being tested?
Conventional physical therapy, Barefoot Whole Body Vibration Training (WBVTb) and Shod Whole Body Vibration Training (WBVTs)
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
36 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Oct 2024to 30 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Between ages of 3 and 18
  • Diagnosed with CP
  • Able to walk at least 10 meters with or without assistive devices
  • GMFCS level 1-3
  • Able to stand independently or with self-support on a vibration platform for 3 minutes
  • Able to understand verbal commands and cooperate during clinical examination

Who cannot join

  • History of lower extremity botulinum toxin injection or surgery in the past 6 months
  • Any bone fracture in the past 8 weeks
  • Acute thrombosis, muscle-tendon inflammation, nephrolithiasis
  • Presence of implants in the spine or lower extremities
  • Pregnancy
  • Presence of mental impairment, visual or hearing loss affecting balance
Show all 10Show fewer
  • History of seizures in the past 6 months
  • ASH 4 spasticity/contracture in any lower extremity muscle group
  • Presence of cardiovascular or pulmonary disease
  • Diagnosis of dyskinetic cerebral palsy

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Trakya University Faculty of Medicine

    Edirne, Merkez, 22030

Other trials in Turkey (Türkiye)

About this study

Official title: Effects of Barefoot vs. Shod Whole Body Vibration Training on Pedobarographic Evaluation, Balance, Endurance and Lower Extremity Functions in Children With Cerebral Palsy: 3-Arm Randomized Controlled Single-Blind Study

Cerebral palsy (CP) refers to a group of lifelong conditions that affect the development of movement and coordination that lead to activity limitations due to damage to the developing fetal or neonatal brain tissue. Although the brain lesion is static, it can lead to progressive musculoskeletal system problems. As a result of the restriction of ankle joint range of motion and many microscopic changes in the muscle structure, plantar pressure distribution is impaired in children with CP which brings about gait and balance problems. Moreover, since physical activity may be restricted due to spasticity, poor motor control, muscle weakness and balance problems; the main goals in CP rehabilitation are normalization of muscle tone, improving walking function by increasing joint range of motion, strength and balance and consequently improving mobility.

There is a need for adjunctive treatment methods with low side effect profiles that can be applied in the long term to prevent musculoskeletal complications and preserve existing functions in children with CP. Whole body vibration training (WBVT), is a therapeutic exercise method that is growing in popularity due to its ease of application, low side effect profile and non-invasiveness as an auxiliary treatment method to traditional rehabilitation programs. Although WBVT is suggested as an easily applicable and safe treatment method with home-type vibration devices; scientific evidence is still lacking and it has not yet been included in routine rehabilitation programs due to the small number of high-quality randomized controlled trials. This study aims to determine the efficacy of barefoot vs. shod WBVT in addition to the conventional physiotherapy, compared to the conventional physiotherapy alone, in children with mild-moderate CP on pedobarographic evaluation, balance, endurance and lower extremity functions. As a result of this study, it might possible to offer children with CP an accessible, safe and helpful treatment method with established protocols.

Read the detailed description

CP describes a group of neurological disorders that occur after damage to the brain during development. Although brain damage is non-progressive; spasticity, poor motor control, muscle weakness and balance problems are frequently observed due to first motor neuron damage. Restriction of physical activity causes joint contractures and bone deformities, which negatively affect muscle strength and motor function. The main goals in CP treatment are to normalize muscle tone, reduce joint stiffness, increase joint range of motion, strength and balance.

In children with CP, while proximal motor function of the lower extremities is generally preserved; calf muscles, which are well-known to greatly influence postural control, are particularly affected by primary impairments such as spasticity, selective motor control deficits and weakness. As gastrocnemius muscle stiffness increases with growth, it undergoes shortening and atrophy; while its antagonist muscle, the tibialis anterior, often becomes weak. In later ages, ankle joint of motion progressively decreases, accompanied by numerous microscopic changes in muscle structure leading to plantar flexion contractures in children with CP. This results in abnormal plantar pressure distribution, contributing to gait and balance problems. Increased plantar flexor activity or knee flexion increases load on the forefoot. Significant differences have been reported in weight distribution on the feet of children with hemiplegic CP. Previous studies suggest that children with CP exhibit distinct plantar pressure patterns.

WBVT is an emerging therapeutic exercise method in addition to traditional rehabilitation, gaining popularity due to its ease of application and low side effect profile. In WBVT, vibration motion generated by the platform stimulates a movement pattern similar to human gait which results in activation of proprioceptive spinal circuits, leading to compensatory rhythmic muscle contractions in the lower extremities and trunk. Studies conducted on adult, adolescent and pediatric individuals with CP report positive effects of WBVT on gross motor function, balance, muscle strength, muscle tone, spasticity, proprioceptive perception, functional activities and walking. In brief, WBVT stands out as a safe, non-pharmacological method to increase muscle mass in specific pediatric populations.

Enhancing balance and lower extremity function is crucial for improving mobilization, a key goal in CP treatment. CP is commonly approached as a pediatric issue, but approximately 90% of individuals with CP reach adulthood and their life expectancy is similar to that of general population. Given that CP is a lifelong condition, there is a need for adjunctive therapies with low side effect profiles that can be applied in the long term to prevent complications and preserve existing functions. WBVT emerges as a promising adjunctive therapy for inclusion in rehabilitation programs for CP. It is non-invasive, easy to administer and has low side effect profile. WBVT can be applied quickly and conveniently with home-based devices, making it a practical treatment option.

Not only is the number of randomized controlled trials limited, but existing studies also have shortcomings such as a lack of specification regarding footwear (shoes/socks/barefoot/assistive devices) used during WBVT, as well as addressing technical terms (frequency, peak-to-peak displacement, amplitude, etc.), type of vibration (side alternating/synchronous), and the types of exercises (static or dynamic) performed on the platform.

In this study, participants will be selected from children diagnosed with CP who are followed up at the pediatric rehabilitation clinic of Trakya University Department of Physical Medicine and Rehabilitation and who meet the inclusion and exclusion criteria. Participants will be randomized into 3 groups at the beginning of the study. Age, gender, more affected extremity, use of orthoses/assistive devices, Gross Motor Function Classification System (GMFCS) level, history of orthopedic surgery and presence of comorbidities will be recorded for all participants. Written informed consent will be obtained from the families of all participants.

Group 1 will receive sham WBVT in addition to conventional physical therapy program. Groups 2 and 3 will receive WBVT with footwear and barefoot, respectively in addition to conventional physical therapy program. This study aims to determine the efficacy of barefoot vs. shod WBVT in addition to the conventional physiotherapy, compared to the conventional physiotherapy alone, in children with mild-moderate CP on pedobarographic evaluation, balance, endurance and lower extremity functions. By addressing the gaps in the literature and establishing the effects of WBVT, it is anticipated that WBVT will contribute to improving mobility, balance and overall quality of life for children with CP. Detailed protocol presentation in this study will contribute to pediatric rehabilitation in clinical practice and shed light on future research.

Being tested
Conventional physical therapy, Barefoot Whole Body Vibration Training (WBVTb), Shod Whole Body Vibration Training (WBVTs), Sham Whole Body Vibration Training (WBVTsh)
Keywords
cerebral palsy, whole body vibration, conventional physical therapy, balance, pedobarographic evaluation, gross motor function, spasticity
Medical subject headings
Cerebral Palsy, Muscle Spasticity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Conventional physical therapyOther

    Conventional physical therapy program will include:

    1. Stretching exercises (forearm pronators, ulnar deviators, shoulder internal rotators, hip flexors and adductors, and hamstring muscle groups)
    2. Strengthening exercises (ankle dorsiflexors, knee extensors, and hip flexor muscle groups)
    3. Posture exercises
    4. Balance and proprioception exercises
    5. Walking training, obstacle crossing training, stair climbing and descending exercises
  • Barefoot Whole Body Vibration Training (WBVTb)Other

    Each WBVT session will consist of the following schedule: 3 minutes of WBVT- 2 minutes rest- 3 minutes of WBVT- 2 minutes rest- 3 minutes of WBVT- 2 minutes rest. Thus a treatment session will last 15 minutes in total. The participants will be barefoot. A specially designed walker will be used to provide support during WBVT for children who are unable to stand independently on the platform and. All exercises and WBVT sessions will be performed under the supervision of a physiotherapist and postural correction will be encouraged through visual feedback (the platform will be placed in front of a mirror) and verbal cueing. One set of WBVT along with the dynamic exercise program to be implemented on the platform is summarized below.

    Stage 1: Semi-squat (knees flexed 10-45º) for 1 minute

    Stage 2: Semi-squat +Calf raise for 1 minute

    Stage 3: Triceps surae stretch for 1 minute

  • Shod Whole Body Vibration Training (WBVTs)Other

    Each WBVT session will consist of the following schedule: 3 minutes of WBVT- 2 minutes rest- 3 minutes of WBVT- 2 minutes rest- 3 minutes of WBVT- 2 minutes rest. Thus a treatment session will last 15 minutes in total. The participants will wear everyday sports shoes. A specially designed walker will be used to provide support during WBVT for children who are unable to stand independently on the platform and. All exercises and WBVT sessions will be performed under the supervision of a physiotherapist and postural correction will be encouraged through visual feedback (the platform will be placed in front of a mirror) and verbal cueing. One set of WBVT along with the dynamic exercise program to be implemented on the platform is summarized below.

    Stage 1: Semi-squat (knees flexed 10-45º) for 1 minute

    Stage 2: Semi-squat +Calf raise for 1 minute

    Stage 3: Triceps surae stretch for 1 minute

  • Sham Whole Body Vibration Training (WBVTsh)Other

    During "Sham" WBVT; the same exercises that the intervention groups will receive on the vibration platform will be performed on the platform for the same duration (3 days per week for 15 minutes each session, over a period of 4 weeks) without the platform being activated.

Study groups in NCT06596525
Study groupRoleWhat they receive
Group 1: Conventional physical therapy (PT) + WBVTsh (sham)Sham comparatorGroup 1 will receive a "sham" WBVT in addition to conventional physical therapy. Over a period of 4 weeks, 3 days per week for 30 minutes each session, participants will engage in conventional physical therapy program.
Receives: Other: Conventional physical therapy; Other: Sham Whole Body Vibration Training (WBVTsh)
Group 2: Conventional physical therapy (PT) + WBVTs (shod)ExperimentalOver a period of 4 weeks, in addition to conventional physical therapy program, the participants will engage in WBVT on commercially available "ThinningPlate" vibration platform, 3 days per week for 15 minutes each session. Group 2 will wear everyday sports shoes during WBVT.
Receives: Other: Conventional physical therapy; Other: Shod Whole Body Vibration Training (WBVTs)
Group 3: Conventional physical therapy (PT) + WBVTb (barefoot)ExperimentalOver a period of 4 weeks, in addition to conventional physical therapy program, the participants will engage in WBVT on commercially available "ThinningPlate" vibration platform, 3 days per week for 15 minutes each session. Group 3 will be barefoot during WBVT.
Receives: Other: Conventional physical therapy; Other: Barefoot Whole Body Vibration Training (WBVTb)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pedobarographic evaluation

    Static and dynamic plantar pressure parameters will be recorded via pedobarographic evaluation platform. All analysis will be carried out on a flat platform at a constant temperature of 18-22 degrees. All participants will receive clear instructions on test protocols and will be recommended to dress in a way that does not impede lower extremity movements.

    Measured: At baseline, at the end of the 4-week treatment (at 4th week), 1 month after the end of treatment (at 8th week)

  2. Balance

    Bipedal, unipedal and sitting balance will be evaluated using balance plates.

    Measured: At baseline, after the end of the treatment (at 4th week), 1 month after the end of treatment (at 8th week).

Secondary outcomes (10)
  1. Bioimpedance analysis

    TANİTA MC 780 multi-frequency segmental body composition analyzer will be used for the assessment.

    Measured: At baseline, after the end of the treatment (at 4th week), 1 month after the end of treatment (at 8th week)

  2. Modified Ashworth Scale (MAS) for lower extremity muscle tone

    For clinical assessment of spasticity of lower extremity muscles, the Modified Ashworth Scale (MAS) will be used. It is based on the subjective grading of resistance felt during examination. MAS grades range from 0 (normal muscle tone) to 4 (extreme spasticity).

    Measured: At baseline, after the end of the treatment (at 4th week), 1 month after the end of treatment (at 8th week)

  3. Pediatric Balance Scale (PBS)

    The Pediatric Balance Scale (PBS) is a highly reliable scale in children with CP and will be used to assess functional balance of the participants. The PBS is an adaptation for children by Franjoine of the Berg Balance Scale. It includes functional movements such as sitting, standing up, transferring, standing on one foot, and picking up objects from the ground, comprising 14 sections scored from 0 to 4 each; the maximum score achievable is 56.

    Measured: At baseline, after the end of the treatment (at 4th week), 1 month after the end of treatment (at 8th week)

  4. Timed up and go (TUG) test

    Functional mobility of the participants will be evaluated through timed up and go (TUG) test. TUG test is a test that evaluates the balance function of an individual during basic mobility. The patient is asked to rise from a chair without using their arms for support, walk at their maximum safe speed for a distance of 3 meters (approximately 10 feet), turn around, return to the chair, and sit down again. This process is repeated three times, and the time taken to complete the task is recorded in seconds. A shorter time indicates better balance performance.

    Measured: At baseline, after the end of the treatment (at 4th week), 1 month after the end of treatment (at 8th week)

  5. Lower extremity muscle strength

    Lower extremity muscle strength will ve evaluated through Medical Research Council (MRC) Scale, which provides a standardized method to quantify muscle strength based on observed movement against resistance. The MRC Scale categorizes muscle strength into grades from 0 to 5: 0 (no contraction), 1 (trace contraction, muscle flicker, but no movement), 2 (active movement with gravity eliminated), 3 (active movement against gravity), 4 (active movement against some resistance), 5 (normal strength, movement against full resistance).

    Measured: At baseline, after the end of the treatment (at 4th week), 1 month after the end of treatment (at 8th week)

  6. Five times sit-to-stand test (5XSST)

    Five times sit-to-stand test (5XSST) will be used to assess lower extremity functional strength and balance. The participant begins the test sitting on the chair with arms crossed over the chest. They are instructed to stand up and sit down from the chair five times as quickly as possible without using arm support. The lowest time recorded from two trials is used as the final score.

    Measured: At baseline, after the end of the treatment (at 4th week), 1 month after the end of treatment (at 8th week)

  7. Gross Motor Function Measure (GMFM-88)

    Gross Motor Function Measure (GMFM-88) is a standardized observational test designed to measure changes in gross motor function in children with CP. It has 5 dimensions of interest: A: Lying and rolling, B: Sitting, C: Crawling and kneeling, D: Standing, E: Walking, running and jumping. A scoring key of 0 (does not initiate), 1 (initiates), 2 (partially completes), 3 (completed) is used; however the parameters such as distance, time, support provided, accuracy, counts and tasks will determine the specific item scores. Item scores are summed to calculate raw and percent scores fro each of the five GMFM-88 dimensions. Dimension percent scores are averaged to obtain an overall total score. Not tested items in the GMFM-88 are scored as "0".

    Measured: At baseline, after the end of the treatment (at 4th week), 1 month after the end of treatment (at 8th week)

  8. 6 minutes walk test

    6-minute walk test will be used to assess the participant's functional status and endurance. It provides an indirect assessment of an individual's capacity during daily life activities and can also be used to monitor progress during treatment. It measures the distance a patient can walk on a flat, hard surface at their maximum speed over a period of 6 minutes. This time-based test is conducted in quiet and enclosed corridors, recording parameters such as effort expended over a specific time period, oxygen saturation, heart rate, blood pressure, respiratory rate, and walking distance.

    Measured: At baseline, after the end of the treatment (at 4th week), 1 month after the end of treatment (at 8th week)

  9. Functional mobility scale (FMS)

    The FMS classifies the functional mobility of children 4-18 years of age with cerebral palsy, taking into account the assistive devices a child might use. Higher scores mean better outcome.

    Measured: At baseline, after the end of the treatment (at 4th week), 1 month after the end of treatment (at 8th week)

  10. The Gillette Functional Assessment Questionnaire (FAQ)

    The Gillette Functional Assessment Questionnaire (FAQ) is a self or proxy-report measure that includes a ten-level classification of ambulatory function (FAQ Walking Scale), and 22 functional locomotor activities rated on a five-level Likert difficulty scale (FAQ 22-item skill set). The FAQ is intended for use in individuals with all levels of walking ability, and focuses on what an individual can do independently with the use of assistive devices or orthoses as needed to maximize function.

    Measured: At baseline, after the end of the treatment (at 4th week), 1 month after the end of treatment (at 8th week)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Sep 2024
  2. Study start1 Oct 2024
  3. Primary completion1 Dec 2025
  4. Study completion30 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
The study will be conducted as a single-blind randomized controlled trial with 3 parallel arms, including 2 experimental groups and 1 control group. Participants will be randomized into 3 groups at the beginning of the study. One arm (Group 1) will be sham comparator and will receive sham WBVT in addition to conventional physical therapy. The other two arms are the experimental groups. Group 2 will receive WBVT with footwear in addition to conventional physical therapy, and Group 3 will receive WBVT with barefoot in addition to conventional physical therapy. Group 1:Conventional physical therapy (PT) + WBVTsh (sham) Group 2: PT + WBVTs (shod) Group 3: PT+ WBVTb (barefoot)
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
36 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06596525
Sponsor's protocol ID
TUTF-GOBAEK 2024/322
Status last verified
Mar 2026
First submitted
11 Sep 2024
Last updated
10 Mar 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Ruck J, Chabot G, Rauch F. Vibration treatment in cerebral palsy: A randomized controlled pilot study. J Musculoskelet Neuronal Interact. 2010 Mar;10(1):77-83.

    PubMed 20190383
  • Leite HR, Camargos ACR, Mendonca VA, Lacerda ACR, Soares BA, Oliveira VC. Current evidence does not support whole body vibration in clinical practice in children and adolescents with disabilities: a systematic review of randomized controlled trial. Braz J Phys Ther. 2019 May-Jun;23(3):196-211. doi: 10.1016/j.bjpt.2018.09.005. Epub 2018 Sep 19.

    PubMed 30245042
  • Sa-Caputo DC, Costa-Cavalcanti R, Carvalho-Lima RP, Arnobio A, Bernardo RM, Ronikeile-Costa P, Kutter C, Giehl PM, Asad NR, Paiva DN, Pereira HV, Unger M, Marin PJ, Bernardo-Filho M. Systematic review of whole body vibration exercises in the treatment of cerebral palsy: Brief report. Dev Neurorehabil. 2016 Oct;19(5):327-33. doi: 10.3109/17518423.2014.994713. Epub 2015 Mar 31.

    PubMed 25826535
  • Young NL. The transition to adulthood for children with cerebral palsy: what do we know about their health care needs? J Pediatr Orthop. 2007 Jun;27(4):476-9. doi: 10.1097/01.bpb.0000271311.87997.e7. No abstract available.

    PubMed 17513974
  • Rauch F, Sievanen H, Boonen S, Cardinale M, Degens H, Felsenberg D, Roth J, Schoenau E, Verschueren S, Rittweger J; International Society of Musculoskeletal and Neuronal Interactions. Reporting whole-body vibration intervention studies: recommendations of the International Society of Musculoskeletal and Neuronal Interactions. J Musculoskelet Neuronal Interact. 2010 Sep;10(3):193-8.

    PubMed 20811143
  • Swolin-Eide D, Magnusson P. Does Whole-Body Vibration Treatment Make Children's Bones Stronger? Curr Osteoporos Rep. 2020 Oct;18(5):471-479. doi: 10.1007/s11914-020-00608-0.

    PubMed 32696294
  • Tekin F, Kavlak E. Short and Long-Term Effects of Whole-Body Vibration on Spasticity and Motor Performance in Children With Hemiparetic Cerebral Palsy. Percept Mot Skills. 2021 Jun;128(3):1107-1129. doi: 10.1177/0031512521991095. Epub 2021 Feb 3.

    PubMed 33535899
  • Martakis K, Stark C, Rehberg M, Semler O, Duran I, Schoenau E. Reference Centiles to Monitor the 6-minute-walk Test in Ambulant Children with Cerebral Palsy and Identification of Effects after Rehabilitation Utilizing Whole-body Vibration. Dev Neurorehabil. 2021 Jan;24(1):45-55. doi: 10.1080/17518423.2020.1770891. Epub 2020 Jun 21.

    PubMed 32564635
  • Wren TA, Lee DC, Hara R, Rethlefsen SA, Kay RM, Dorey FJ, Gilsanz V. Effect of high-frequency, low-magnitude vibration on bone and muscle in children with cerebral palsy. J Pediatr Orthop. 2010 Oct-Nov;30(7):732-8. doi: 10.1097/BPO.0b013e3181efbabc.

    PubMed 20864862
  • Ko MS, Sim YJ, Kim DH, Jeon HS. Effects of Three Weeks of Whole-Body Vibration Training on Joint-Position Sense, Balance, and Gait in Children with Cerebral Palsy: A Randomized Controlled Study. Physiother Can. 2016;68(2):99-105. doi: 10.3138/ptc.2014-77.

    PubMed 27909356
  • Tupimai T, Peungsuwan P, Prasertnoo J, Yamauchi J. Effect of combining passive muscle stretching and whole body vibration on spasticity and physical performance of children and adolescents with cerebral palsy. J Phys Ther Sci. 2016 Jan;28(1):7-13. doi: 10.1589/jpts.28.7. Epub 2016 Jan 30.

    PubMed 26957720
  • El-Shamy SM. Effect of whole-body vibration on muscle strength and balance in diplegic cerebral palsy: a randomized controlled trial. Am J Phys Med Rehabil. 2014 Feb;93(2):114-21. doi: 10.1097/PHM.0b013e3182a541a4.

    PubMed 24434887
  • Ahlborg L, Andersson C, Julin P. Whole-body vibration training compared with resistance training: effect on spasticity, muscle strength and motor performance in adults with cerebral palsy. J Rehabil Med. 2006 Sep;38(5):302-8. doi: 10.1080/16501970600680262.

    PubMed 16931460
  • Unger M, Jelsma J, Stark C. Effect of a trunk-targeted intervention using vibration on posture and gait in children with spastic type cerebral palsy: a randomized control trial. Dev Neurorehabil. 2013;16(2):79-88. doi: 10.3109/17518423.2012.715313.

    PubMed 23477461
  • Saquetto M, Carvalho V, Silva C, Conceicao C, Gomes-Neto M. The effects of whole body vibration on mobility and balance in children with cerebral palsy: a systematic review with meta-analysis. J Musculoskelet Neuronal Interact. 2015 Jun;15(2):137-44.

    PubMed 26032205

Questions about this trial

What is this clinical trial studying?

A study testing Conventional physical therapy, Barefoot Whole Body Vibration Training (WBVTb) and Shod Whole Body Vibration Training (WBVTs) in people with Cerebral Palsy (CP), run by Trakya University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pedobarographic evaluation (time frame: At baseline, at the end of the 4-week treatment (at 4th week), 1 month after the end of treatment (at 8th week)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06596525, which also lists 25 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in